What should be the APRV (Airway Pressure Release Ventilation) settings on the ventilator for a 57‑year‑old female with ARDS, weight 50 kg, height 156 cm, and a plateau pressure of 27 cm H₂O?

APRV Settings for This ARDS Patient

For this 57-year-old female with ARDS (50 kg, 156 cm, plateau pressure 27 cmH₂O), I recommend starting with conventional lung-protective ventilation rather than APRV, using tidal volumes of 4-6 ml/kg predicted body weight (approximately 200-300 mL) and maintaining plateau pressure ≤30 cmH₂O 1.

Why Not APRV as First-Line?

The strongest available evidence—the 2017 ATS/ERS/SCCM Clinical Practice Guidelines—provides strong recommendations for lung-protective ventilation with low tidal volumes (4-8 ml/kg PBW) and plateau pressures <30 cmH₂O, but does not recommend APRV as a standard approach 1. These guidelines are based on moderate-to-high quality evidence demonstrating mortality benefit with conventional lung-protective strategies.

Critical Context:

• Your patient's plateau pressure of 27 cmH₂O is already within acceptable limits (<30 cmH₂O)
• There is no high-quality evidence that APRV improves mortality compared to conventional ventilation 2
• APRV is typically reserved as rescue therapy for difficult-to-oxygenate patients who fail conventional ventilation 2

If You Must Use APRV (Rescue Scenario)

Should conventional ventilation fail to maintain adequate oxygenation, here are evidence-informed APRV settings:

Initial APRV Parameters:

P-high (High Pressure):

• Set equal to current plateau pressure: 27 cmH₂O 3, 4
• Alternative approach: Mean airway pressure + 2-5 cmH₂O
• Maximum safe limit: 35 cmH₂O 3

P-low (Low Pressure):

• 0 cmH₂O 3, 4
• This is the most consistent recommendation across studies

T-high (High Time):

• 4-6 seconds 3, 4
• This extended inspiratory time allows for alveolar recruitment

T-low (Low Time):

• 0.4-0.8 seconds 3
• More precisely: Set to terminate expiratory flow at 75% of peak expiratory flow 5, 4
• This "release time" prevents derecruitment and is the most physiologically sound approach

Critical Safety Limits:

Release Tidal Volume:

• Maximum 4-6 ml/kg PBW during the release phase 3
• For this 50 kg patient with PBW ~45 kg: 180-270 mL maximum
• Monitor closely—APRV can generate excessive tidal volumes leading to volutrauma

Transpulmonary Pressure:

• Despite potentially high plateau pressures (up to 34 cmH₂O in studies), transpulmonary pressure should remain safe if chest wall compliance is reduced 6
• This is particularly relevant in extrapulmonary ARDS (sepsis, peritonitis)

Major Pitfalls and Caveats:

1. Lack of Standardization

There is substantial variability in APRV practice with no consensus on optimal settings 3, 4, 7. The most common barrier to APRV use is lack of institutional protocols and training 3, 7.

2. Risk of Excessive Volumes

Survey data shows that practitioners often accept release volumes and plateau pressures that exceed lung-protective limits 4. You must vigilantly monitor and limit tidal volumes during the release phase.

3. T-low Setting Confusion

Only 47% of practitioners correctly use expiratory flow to set T-low 4. The 75% peak expiratory flow termination rule is physiologically superior to arbitrary time settings 5.

4. Not a Mortality-Proven Strategy

Unlike low tidal volume ventilation, APRV lacks solid proof of mortality benefit 2. Use it only when conventional strategies fail.

Recommended Approach for This Patient:

1. Start with conventional lung-protective ventilation:

   • Tidal volume: 4-6 ml/kg PBW (200-270 mL for ~45 kg PBW)
   • Plateau pressure: Already acceptable at 27 cmH₂O
   • PEEP: Higher PEEP strategy if moderate-severe ARDS 1
   • Consider prone positioning if severe ARDS (PaO₂/FiO₂ <100) 1

2. Reserve APRV for rescue if:

   • Refractory hypoxemia despite optimized conventional ventilation
   • Inability to maintain adequate oxygenation with lung-protective settings
   • Institutional protocol and expertise available

3. If using APRV, implement strict monitoring:

   • Continuous assessment of release tidal volumes
   • Adjustment of T-low based on expiratory flow waveform
   • Regular evaluation for transition back to conventional modes

The evidence strongly supports conventional lung-protective ventilation as first-line therapy, with APRV reserved for carefully selected rescue scenarios where institutional expertise exists 1, 2.